Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • TOP STORY: Dairy farmers seek final approval of $50M settlement in milk price fixing action
    • ACQUISITIONS & MERGERS NEWS: EC approves acquisition of 7S Group by ManpowerGroup
    • ANTITRUST NEWS: Exemption for college financial aid collaboration extended into 2022
    • ANTITRUST—D. Minn.: Arctic Cat’s counterclaims in patent dispute skid away
    • FRANCHISING & DISTRIBUTION NEWS: Wingate Inns seeks $615K for franchisee’s unilateral termination
    • LAW FIRM NEWS: Data privacy advisor Norma Krayem joins Holland & Knight
    • PRIVACY—M.D. Fla.: Consumers failed to show debt collector’s calls linked to an alleged debt
    • STATE UNFAIR TRADE PRACTICES—D. Conn.: Consumer electricity supply contract may be unfair or deceptive under CUTPA
    • STATE UNFAIR TRADE PRACTICES—Mass. App.: Insurance company evades consumer’s deceptive acts claims
    • STATE UNFAIR TRADE PRACTICES—N.D. Cal.: State law breach of warranty and consumer fraud claims involving roll-out rack on Whirlpool oven collapse
    • WORTH NOTING—Other Antitrust and Trade Regulation developments
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Antitrust Law Daily Wrap Up, WORTH NOTING—Other Antitrust and Trade Regulation developments, (Aug 7, 2015)

    A periodic roundup of other items of interest to the Antitrust and Trade Regulations community:

    ANTITRUST NEWS: The U.K. Competition and Markets Authority (CMA) has issued a statement of objections to pharmaceutical suppliers Pfizer and Flynn Pharma, ...

    A periodic roundup of other items of interest to the Antitrust and Trade Regulations community:

    ANTITRUST NEWS: The U.K. Competition and Markets Authority (CMA) has issued a statement of objections to pharmaceutical suppliers Pfizer and Flynn Pharma, claiming that the companies breached U.K. and European Union (EU) competition law by charging excessive, unfair prices in the United Kingdom for phenytoin sodium capsules. The statement of objections concerns the prices Pfizer charged Flynn Pharma, as well as the prices that Flynn Pharma has charged its customers since September 2012. “The prices that the CMA is concerned about in this case are very high compared to those prices previously charged and have led to a big increase in the total NHS drug bill for what is a very important drug for tens of thousands of patients,” stated CMA Senior Director of Antitrust Enforcement, Ann Pope.

    AGENCY NEWS: In an effort to expand and strengthen its Cartels and Criminal Group, the U.K. Competition and Markets Authority (CMA) has appointed Deborah Wilkie as Director of Civil Cartel Enforcement. Wilkie will join existing Director Juliette Enser to lead an expanded civil cartel enforcement team. She will also act as project director on Competition Act cartel cases and will play a leading role in the CMA’s policy work on cartels and leniency. Wilkie was previously an Assistant Director in the CMA’s civil cartel enforcement team.

    News: Antitrust

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use